ARTICLES ON VALVULOPATHIES
AUTHEARTVISIT study: the Austrian paradigm
This retrospective observational study, adjusted through propensity score analysis, utilized data from the Austrian National Health System registry to compare mid- to long-term survival in patients treated with surgery or TAVI between 2010 and 2020.
Valvular surgery in infective endocarditis according to frailty risk scales: are data at the service of science or is science at the service of data?
A retrospective study using data from the U.S. National Inpatient Sample (NIS) to analyze patients diagnosed with infective endocarditis, evaluating the impact of valvular surgery according to frailty risk scores.
Infective endocarditis as a primary focus… are we globally addressing the problem?
This multicenter study evaluates the impact of spondylodiscitis associated with infective endocarditis on recurrence and survival based on the treatment sequence employed.
Consensus document from the AATS on the management of neonatal and infantile Ebstein anomaly
Consensus document on the management of Ebstein anomaly by the Clinical Practice Standards Committee of the American Association for Thoracic Surgery (AATS)
The Ebstein anomaly and the difficulty in drawing conclusions for decision-making
Results from the experience of six centers in Australia and New Zealand in the management of Ebstein anomaly over 34 years.
On-X® Aortic Prosthesis Carriers in Aortic Position: Is This the End of Anticoagulation Demonization?
This study confirms the findings of the PROACT trial on the safety profile of reducing oral anticoagulation in patients with an On-X® prosthetic valve in the aortic position.
What does closing the left atrial appendage during mitral repair offer in patients without atrial fibrillation?
This single-center, retrospective study compares the utility of left atrial appendage (LAA) closure in patients undergoing mitral valve repair without atrial fibrillation (AF).
Inspiris Resilia in pulmonary position: a warning
A retrospective single-center study comparing outcomes of the Inspiris Resilia bioprostheses versus Mosaic.
The Dark Side of TAVI: Results from the International Explant Registry
Periprocedural and one-year mortality and perioperative outcomes from TAVI device explants across various etiologies, as recorded in the EXPANT-TAVR international registry.
Aortic Valve Replacement with Carpentier Edwards Magna Ease® Bioprosthesis: A Decade of Follow-Up
This article retrospectively analyzes clinical and hemodynamic outcomes in 689 adults who underwent surgical aortic valve replacement with the Carpentier Edwards Magna Ease® bioprosthesis over a ten-year follow-up.